Home›Companies›Biotech & Pharma›Med Aditus Pharmaceuticals

Med Aditus Pharmaceuticals, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 6, 2024·Suggest an edit

About Med Aditus Pharmaceuticals

Med Aditus Pharmaceuticals is a private company based in Rtp, North Carolina, incorporated in 2023 in Delaware. It has reported $0 raised in one offering on Form D since November 2024. Its chief executive is Dhiren Thakker.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetNov 6, 2024$0of $5.0M target0—Debt, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Med Aditus Pharmaceuticals's Form D filed Nov 6, 2024.

DS
KW
Kay Wagoner
Director
KR
Khama Rogo
Director
MG
Mary Gunn
Director
DT
Dhiren Thakker
President and CEO, director

Sources

  1. SECMed Aditus Pharmaceuticals, Inc. filing history